Africa: Gilead Refuses to Sell Groundbreaking HIV Prevention Drug to MSF
Blocking humanitarian organizations from accessing a medical breakthrough puts vulnerable people across the world in danger. In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company…
